Shanghai Rongtai Health Technology Corporation Limited
Shanghai Stock ExchangeTotal Valuation
Shanghai Rongtai Health Technology Corporation Limited carries a market capitalization of 3.78B, placing it among publicly traded companies globally. Its enterprise value stands at 4.92B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.78B |
| Enterprise Value | 4.92B |
Share Statistics
Shanghai Rongtai Health Technology Corporation Limited currently has 177.40M shares outstanding.
| Shares Outstanding | 177.40M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Shanghai Rongtai Health Technology Corporation Limited trades at a trailing price-to-earnings ratio of 28.87. The price-to-sales ratio is 3.03, and the price-to-book ratio stands at 3.33.
| PE Ratio | 28.87 |
| PS Ratio | 3.03 |
| PB Ratio | 3.33 |
| P/TBV Ratio | 2.45 |
| P/FCF Ratio | 33.58 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Shanghai Rongtai Health Technology Corporation Limited trades at an EV/EBITDA multiple of 32.05 and an EV/FCF ratio of 29.73. The EV/Sales ratio of 3.11 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 32.05 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.11 |
| EV / EBITDA | 32.05 |
| EV / EBIT | 32.05 |
| EV / FCF | 29.73 |
Financial Position
Shanghai Rongtai Health Technology Corporation Limited maintains a current ratio of 3.08, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 42.63, indicating elevated leverage, while an interest coverage ratio of 7.65 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 3.08 |
| Quick Ratio | 1.09 |
| Debt / Equity | 42.63 |
| Debt / EBITDA | 5.71 |
| Interest Coverage | 7.65 |
Financial Efficiency
Shanghai Rongtai Health Technology Corporation Limited posts a return on equity of 12.00 and a return on invested capital of 4.46.
| Return on Equity (ROE) | 12.00 |
| Return on Assets (ROA) | 4.88 |
| Return on Invested Capital (ROIC) | 4.46 |
| Return on Capital Employed (ROCE) | 8.07 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 7.20 |
Taxes
Over the trailing twelve months, Shanghai Rongtai Health Technology Corporation Limited has paid 31.60M in income taxes, reflecting an effective tax rate of 15.99.
| Income Tax | 31.60M |
| Effective Tax Rate | 15.99 |
Stock Price Statistics
Shanghai Rongtai Health Technology Corporation Limited's stock has declined approximately -31.00944% over the past 52 weeks. The 50-day moving average sits at 20.18, while the 200-day moving average is 24.07.
| Beta (5Y) | N/A |
| 52-Week Price Change | -31.00944% |
| 50-Day Moving Average | 20.18 |
| 200-Day Moving Average | 24.07 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Shanghai Rongtai Health Technology Corporation Limited generated 1.58B in revenue and converted that into 165.95M in net income, yielding earnings per share of 0.91. EBITDA reached 153.52M, while operating income came in at 153.52M.
| Revenue | 1.58B |
| Gross Profit | 495.63M |
| Operating Income | 153.52M |
| Pretax Income | 197.58M |
| Net Income | 165.95M |
| EBITDA | 153.52M |
| EBIT | 153.52M |
| Earnings Per Share (EPS) | 0.91 |
Balance Sheet
Shanghai Rongtai Health Technology Corporation Limited holds 749.50M in cash and equivalents against 876.11M in total debt, resulting in a net debt position of 146.37M. Total book value stands at 1.44B, with working capital of 1.43B providing operational flexibility.
| Cash & Cash Equivalents | 749.50M |
| Total Debt | 876.11M |
| Net Debt | 146.37M |
| Equity (Book Value) | 1.44B |
| Book Value Per Share | 8.19 |
| Working Capital | 1.43B |
Cash Flow
After subtracting -148.63M in capital expenditures, free cash flow totaled -148.63M - equivalent to -0.85 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -148.63M |
| Free Cash Flow | -148.63M |
| FCF Per Share | -0.85 |
Margins
Shanghai Rongtai Health Technology Corporation Limited operates with a gross margin of 31.33, reflecting its pricing power and cost economics. The operating margin of 9.70 and net profit margin of 10.49 provide insight into operational efficiency.
| Gross Margin | 31.33 |
| Operating Margin | 9.70 |
| Pretax Margin | 12.49 |
| Profit Margin | 10.49 |
| EBITDA Margin | 9.70 |
Dividends & Yields
The company's payout ratio of 75.45 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.71 |
| Dividend Yield | N/A |
| Payout Ratio | 75.45 |
| Shareholder Yield | 3.25 |
| FCF Yield | 2.98 |
Stock Splits
Shanghai Rongtai Health Technology Corporation Limited's most recent stock split took place on June 5, 2024 with a 10:13 split ratio.
| Last Split Date | 6/5/2024 |
| Split Ratio | 10:13 |
Scores
Shanghai Rongtai Health Technology Corporation Limited posts an Altman Z-Score of 3.71, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.71 |